Monkeypox, Covid Vaccines, And What Tablet Use Is Doing To Our Children

Play Video

Dr. Steven Quay engages in an in-depth conversation with NewsNation, offering valuable guidance on essential topics to discuss with your doctor regarding the latest Coronavirus boosters. In addition, he provides an analysis of the World Health Organization’s recent decision to declare monkeypox a global emergency, exploring the implications and significance of this declaration. Furthermore, Dr. Quay shares his expert opinion on the effects of tablet use on children’s development, discussing potential benefits and concerns associated with increased screen time. His insights aim to equip viewers with a better understanding of these pressing health issues.

Here is a breakdown of the three main topics:

Monkeypox:

Dr. Quay reassures that monkeypox, although declared a global emergency by WHO, is not a major epidemic threat. He explains that it spreads through direct contact with lesions, not through the air or asymptomatically, and is predominantly transmitted among men through sexual contact.

COVID-19 Boosters:

Dr. Quay discusses current COVID-19 concerns, noting high levels of infection in wastewater but less worry about severe cases in emergency rooms due to widespread natural immunity and less severe variants. He advises caution regarding new vaccine boosters, recommending that individuals consult their healthcare providers and consider an IG4 test to determine if their immune system has developed tolerance to previous vaccinations.

Tablets and Toddlers:

He comments on a study linking increased tablet use in young children to more behavioral outbursts. Dr. Quay argues that excessive tablet use can hinder important developmental milestones, such as socialization and physical interaction, which are crucial for toddlers’ growth and learning.

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Related Content

This summer saw a rise in COVID-19 infections across the U.S., driven by a new variant. To address this, updated vaccines from Moderna and Pfizer have been approved by the FDA and will be available this fall. The CDC notes the virus has been evolving, making regular vaccinations important, especially for those with underlying health conditions.

Los casos de COVID-19 están aumentando ligeramente en EE. UU., y se introducirá una nueva vacuna este otoño. Telemundo20 en Texas conversa con el Dr. Quay para discutir los datos más recientes sobre esta vacuna y las precauciones que las personas deben considerar para los próximos meses. A pesar de la presencia continua del virus, actualmente es menos infeccioso y se asemeja a un resfriado común en términos de transmisión.

Dr. Steven Quay is joined by Senator Rand Paul and Richard H. Ebright, Board of Governors professor of chemistry and chemical biology at Rutgers University. They discuss the lab leak theory of COVID-19 in detail.